Filing Details
- Accession Number:
- 0001179110-15-006453
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-20 16:26:04
- Reporting Period:
- 2015-03-29
- Filing Date:
- 2015-04-20
- Accepted Time:
- 2015-04-20 16:26:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1427944 | M. James Roach | C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142 | Senior Vp, Development And Chi | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-03-29 | 6,750 | $0.00 | 113,405 | No | 4 | D | Direct | |
| Common Stock | Acquisiton | 2015-04-16 | 50,000 | $7.41 | 163,405 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-04-16 | 6,215 | $17.08 | 157,190 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2015-04-16 | 50,000 | $18.70 | 107,190 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | D | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to purchase stock | Acquisiton | 2015-04-16 | 50,000 | $0.00 | 50,000 | $7.41 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 97,500 | 2012-02-22 | 2018-02-22 | No | 4 | M | Direct |
Footnotes
- Represents a decrease of 6,750 shares of restricted common stock, $0.0001 par value per share, pursuant to the related restricted stock agreement, as amended, between Mr. Roach and the Company. The shares were awarded pursuant to the Company's 2004 Stock Incentive Plan, as amended.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2014.
- Represents the number of shares of restricted common stock returned to the company to meet minimum tax liability requirements, pursuant to the related restricted stock agreement, as amended, between Mr. Roach and the Company. The shares were awarded pursuant to the Company's 2004 Stock Incentive Plan, as amended.
Billionaire Hedge Funds
